Distonal

Quick links to important sections

Distonal

Method of action: Psychoanaleptics

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Distonal

Quick Facts

Property Description
Active ingredient Desipramine hydrochloride
Form Tablet or Capsule (Oral)
Pharmacological class Tricyclic Antidepressant (TCA)
Common use Modulation of mood imbalance
Origin Synthetic compound

What Type of Medicine is Distonal?

Distonal is a prescription-only medication specifically identified by its active ingredient, Desipramine hydrochloride (Desipramine), which belongs to the Tricyclic Antidepressant (TCA) pharmacological class, a category of psychoactive agents clinically recognized for modulating neurotransmitter activity. This synthetic compound is manufactured as a single-ingredient drug, exclusively prepared for oral administration typically available in a solid pharmaceutical preparation, such as a tablet or capsule.

The drug's structure is based on the dibenzazepine system. Notably, Desipramine is classified as a secondary amine TCA, a differentiating factor from older, tertiary amine agents. This specific chemical composition provides Distonal with a more selective pharmacological profile, a characteristic supported by pharmacological studies. The dosage form is intended for adult patients requiring systemic antidepressant therapy.

What is the General Purpose of Distonal?

The general purpose of Distonal is to modulate crucial chemical signaling within the brain to help manage mood and emotional stability. Its classification as an Antidepressant dictates that its utility is centered on addressing neurochemical imbalances, which is the therapeutic focus for conditions such as Major Depressive Disorder (MDD). A typical, neutral use scenario involves establishing and maintaining neurochemical balance to help sustain mood regulation.

The drug achieves this purpose through its foundational role as a potent Norepinephrine Reuptake Inhibitor (NRI). This selective action increases the availability of the neurotransmitter norepinephrine within the neural synapses. The medical community recognizes that normalizing this key neurotransmitter activity is the physiological basis for the drug's general objective in stabilizing mood and promoting an improved sense of well-being.

What side effects are possible with Distonal?

Possible side effects and safety information

Regulatory documents organize the safety profile of Distonal (Desipramine hydrochloride) based on how often adverse reactions may occur and which body systems are affected, providing a descriptive framework for potential risks.

Adverse Reaction Classification

Adverse reactions are formally grouped by the system-organ class (SOC), which includes Nervous System Disorders, Cardiac Disorders, Vascular Disorders, Gastrointestinal Disorders, and Psychiatric Disorders.

Reactions are also classified by frequency. Common effects frequently cited in regulatory texts include dry mouth, sedation, orthostatic hypotension (postural dizziness), constipation, and tremor. Effects categorized as Uncommon or Rare include severe events such as cardiac arrhythmias, certain blood dyscrasias (e.g., agranulocytosis), and seizures.

Serious Adverse Reactions and Population-Specific Safety

Official labeling contains specific warnings for serious adverse reactions. A mandatory regulatory note highlights an increased risk of suicidal ideation and behavior in children, adolescents, and young adults (up to 24 years) during the initial months of treatment or following dose adjustments. Furthermore, the potential for clinically significant cardiac toxicity is a documented safety element.

Regulatory documents also specify population-specific safety considerations. Older adults may have heightened susceptibility to specific anticholinergic effects (e.g., confusion, urinary retention) and orthostatic hypotension. Time-related patterns are noted, indicating that the risks associated with suicidality are typically highest during the initial phase of treatment.

Use of Distonal is subject to safety-related restrictions, notably being restricted for concurrent use with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of severe reactions like Serotonin Syndrome.

Overdose and Emergency Response

Overdose involving Distonal (Desipramine hydrochloride) is officially documented as a severe event requiring immediate medical intervention due to the high risk of life-threatening outcomes. The regulatory profile focuses on critical signs of toxicity and mandated emergency responses.

Documented Clinical Presentations Toxicity is officially documented to present with rapid-onset cardiovascular and neurological signs. Cardiovascular manifestations listed include cardiac dysrhythmia, irregular heartbeats, and critical hypotension. Central Nervous System (CNS) toxicity is characterized by seizures (convulsions), stupor, confusion, and coma. Severe outcomes can include circulatory shock, fatal outcome, and the development of wide-complex arrhythmia or Serotonin Syndrome.

Required Emergency Actions and Supportive Measures Regulatory guidance mandates that immediate medical attention be sought at the first suspicion of overdose, requiring immediate contact with emergency services. Official labeling details that management is strictly symptomatic and supportive. Procedural steps include the use of activated charcoal for gastric decontamination and continuous ECG monitoring. Sodium bicarbonate is explicitly described as a treatment for associated cardiac abnormalities. Prolonged hospital observation for a minimum of six hours is required following suspected exposure to assess for delayed severe effects.

Therapeutic Uses of Distonal

What Distonal Treats: Main Uses and Benefits

Distonal is generally used in the management of conditions presenting with systemic or localized discomfort and is applied across therapeutic domains where additional symptomatic support is needed. The medication is considered relevant for easing symptoms related to affective stability.

It is commonly used in the management of Major Depressive Disorder (MDD), and is also applied in addressing symptoms related to chronic neuropathic pain syndromes, Bulimia nervosa, and specific behavioral symptoms like inattention or hyperactivity. It helps address symptom clusters that may become intense or disruptive, such as persistent low mood, emotional instability, and the prominent loss of pleasure (anhedonia).

This supportive therapeutic benefit contributes to easing the overall symptom load during periods of heightened distress.

“The relief offered... helps patients cope more steadily with the challenging and often disruptive manifestations of nerve pain.”

Quick Fact: Relief for
Neuropathic Pain and Emotional Instability

Regulatory References

  1. NIH StatPearls overview

Eligibility and Restrictions for Use

Eligibility Scope

The official label designates Adults with Major Depressive Disorder (MDD) as the approved population. Conversely, the medicine is contraindicated and must not be used by specific groups.

Populations for whom use is contraindicated:

  • Patients with a known hypersensitivity or allergy to the medicine.
  • Individuals in the acute recovery period following myocardial infarction (MI).
  • Patients who are concurrently receiving, or have received within 14 days, a Monoamine Oxidase Inhibitor (MAOI) drug.
  • Patients with, or suspected of having, Brugada Syndrome.

Eligibility-Related Restrictions

Age Rules: The drug is not approved for children and adolescents (under 18) for the treatment of MDD. Use in older adults requires specific caution due to increased risk of toxic reactions.

Conditional Use: Use requires extreme caution for patients with pre-existing cardiovascular disease, a history of seizure disorders, thyroid disease, urinary retention, glaucoma, or significant renal impairment.

Reproductive Status: Safe use during pregnancy and lactation has not been established. Regulatory guidance advises a decision to discontinue nursing or discontinue the drug.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions between Distonal and other products may occur, which can potentially change how Distonal works, increase its side effects, or alter the effects of the other substances. These interactions generally fall into two categories: pharmacokinetic and pharmacodynamic.

Pharmacokinetic Interactions

These interactions affect the way the body handles the medicine, influencing its absorption, distribution, metabolism, or excretion. For example, if Distonal is metabolized by certain liver enzymes (Cytochrome P450 enzymes) and is combined with an inhibitor of these enzymes, the concentration of Distonal in the bloodstream may increase, potentially raising the risk of adverse effects. Conversely, combining it with an enzyme inducer could lower Distonal’s concentration, potentially reducing its effectiveness.

Pharmacodynamic Interactions

These interactions occur when two medicines affect the same biological target or pathway, resulting in additive, synergistic, or antagonistic effects. For instance, combining Distonal with another medication that causes a similar side effect, such as drowsiness, may lead to an increased or excessive level of that shared effect.

Interacting Product Category Potential Effect
Strong CYP450 Inhibitors May increase Distonal concentration.
Products causing sedation May increase feelings of drowsiness/dizziness.

It is important to provide a complete list of all products being used, including prescription drugs, over-the-counter medicines, herbal supplements, and vitamins, to a healthcare professional to allow for a comprehensive evaluation of potential interactions and necessary adjustments.

Mechanism of Action

How Distonal Works

Distonal's pharmacodynamic action is centered on engaging mechanisms that influence pathways associated with heightened physiological responses. Its effect initiates within systems where specific neurotransmitters or mediators dominate, resulting in the downstream modulation of cellular pathway activity.


Modulation of Receptor-Mediated Signaling

The molecule's primary action involves its interaction with specific receptor or enzyme-mediated signaling pathways. Distonal modifies early molecular steps, thereby suppressing or initiating distinct signaling sequences. This action contributes to a quantifiable reduction in excessive mediator activity and influences the basal activation state within the targeted pathways.


Influence on Pathway Feedback Regulation

Distonal engages mechanisms relevant in systems requiring targeted adjustments to pathway activity. It acts within mechanistic cascades characterized by multiple layers of activation, specifically by influencing feedback regulation within those pathways. This process results in the modulation of overactive physiological responses, driving defined, systemic physiological shifts.

Dosage and Administration Information

Instruction Map: How to Use Distonal — Administration Guidelines

This section outlines the administration instructions for Distonal (desipramine hydrochloride), focusing strictly on proper usage procedures.


Administration Scope

Feature Instruction
Route of administration Oral administration, typically using tablet or capsule formulations.
Dosing schedule (Adults) Usual range: 100 mg to 200 mg per day. The adult maximum dose is 300 mg per day.
Timing in relation to meals Can be taken with or without food.
Preparation requirements No preparation steps (e.g., dilution) are required; the medication is swallowed whole.
Age-group administration rules Adolescents and Older Adults (Geriatric): Usual dose is 25 mg to 100 mg daily. The maximum recommended dose for these groups is 150 mg per day.
Missed-dose rules If a dose is missed, take it as soon as possible, but skip the missed dose if it is almost time for the next scheduled dose. Do not take a double dose.
Special procedural conditions The initiation of treatment requiring the 300 mg daily maximum dose is generally recommended to be started in a hospital setting under close supervision.

Instruction Classifications

Classification Description
Administration method type Oral.
Frequency pattern Daily schedule; initial therapy may be divided, but maintenance is typically a once-daily dose (often at bedtime).
Use-context constraints A 14-day medication-free interval is required when switching from a Monoamine Oxidase Inhibitor (MAOI) to Distonal.

Resulting Procedural Structure

Step Sequence:

  • Initiate therapy at a low daily dose and increase the dosage gradually according to tolerance and response.
  • Administer the total daily dosage either in divided portions or as a single dose once per day.
  • Following symptom control, the dosage should be reduced to the lowest effective level required for maintenance.
  • When discontinuing the drug, the dosage must be tapered gradually.

Connection to the Overall Use Protocol: The protocol mandates a controlled approach to using Distonal, defined by a gradual dose titration procedure and strict maximum dose limits that differ by age group. The instructions establish a flexible but consistent once-daily pattern for ongoing use while imposing critical washout periods to manage transitions with certain other drug classes.

Recent Clinical Evidence

Distonal: Recent Clinical Evidence

The clinical evaluation for Distonal has been conducted across several different clinical areas. The research collected and reviewed by regulators and scientific bodies describes the types of clinical trials that have been conducted, the ways that patient outcomes were measured, and what remains uncertain about its effects.


Evidence for use in Major Depressive Disorder (MDD)

The research base for Distonal was studied through Randomized Controlled Trials (RCTs). These trials explored how symptoms change over time in adult populations, using specific scales to assess depressive symptom change and global clinical status. Trials typically monitored response over short-term intervals (6–8 weeks) and maintenance studies observed recurrence of symptoms for up to two years. Research in adolescent trial cohorts has sometimes presented mixed findings or variability in outcomes, and studies noted that the initial phase for younger populations was associated with specific risk patterns.


Evidence for use in Chronic Neuropathic Pain Syndromes and Bulimia Nervosa

The research base primarily consists of placebo-controlled trials for Chronic Neuropathic Pain Syndromes, focusing on measuring pain intensity and daily functioning. The evidence was observed in some studies as having low certainty, with trials often using modest sample sizes.

Research for Bulimia Nervosa was studied for outcomes related to binge eating episodes and purging behaviors. This evidence is limited by typical trial durations of approximately six weeks and notes of high rates of participant discontinuation.


Long-Term Data and Research Uncertainty

Research for MDD includes data from maintenance studies that explored monitoring symptom recurrence for up to two years. However, long-term effects are not fully established for the chronic neuropathic pain and Bulimia Nervosa indications. The evidence base includes data on older adults, but for adolescent cohorts and behavioral symptoms, the data for certain groups remain insufficient. Because the follow-up durations were limited and the evidence quality varies across studies, certainty remains low for many long-term or comparative outcomes.

Key Studies & References

  1. Desipramine (StatPearls)
  2. Desipramine Hydrochloride Tablet FDA Label (Monograph)

Frequently Asked Questions (FAQ)

Common questions about Distonal (FAQ)


Q: How quickly can someone expect Distonal to start working?

A: Studies and official information indicate that the full effectiveness of Distonal is typically assessed over short-term intervals of 6 to 8 weeks in clinical trials. This suggests that achieving the intended benefit often requires consistent use over several weeks. The gradual dose adjustment process is often included within this initial time frame, reflecting the controlled approach to its use.


Q: How long do the effects of Distonal typically last after taking a dose?

A: According to official product information, the time it takes for the body to eliminate half of the medicine (its half-life) is approximately 12 to 30 hours. This long duration of action is why maintenance therapy is often prescribed as a once-daily dose.


Q: Can Distonal be taken with common over-the-counter pain relievers?

A: Regulatory documents state that a healthcare professional must be informed of all products used, including any over-the-counter medicines, supplements, or pain relievers. This allows them to check for potential effects on how the body handles the medicine or for any increased risk of side effects.


Q: What are the most commonly reported side effects of Distonal?

A: Commonly reported effects cited in regulatory documents include dry mouth, sedation (feeling drowsy), constipation, tremor (shaking), and orthostatic hypotension (dizziness upon standing). Official product information organizes all potential adverse reactions by frequency for review.


Q: Can Distonal affect my sleep patterns?

A: Yes, official documents list sedation as a common adverse reaction, which can affect overall sleep quality or timing. Difficulty sleeping (insomnia) has also been noted as a possible side effect of the medicine. These effects relate to the drug's influence on the nervous system.


Q: Can taking Distonal cause changes in weight?

A: Weight gain has been reported as a possible side effect associated with the use of this type of medicine. This information is included in the official adverse reaction data for the drug.


Q: Is it safe to drink alcohol in moderation while taking Distonal?

A: Regulatory warnings state that combining Distonal with alcohol may cause an exaggerated response to alcoholic beverages due to potential additive effects on the central nervous system. This increased effect may raise the risk of drowsiness and other side effects. The use of alcohol while taking this medicine is information typically reviewed by a healthcare professional.


Q: Is Distonal available as a generic medicine?

A: Yes. The active ingredient in Distonal, desipramine hydrochloride, is available in the market as a generic version in addition to brand-name products.


Q: Are there different strengths or formulations of Distonal available?

A: According to official regulatory documents, the medicine is available for oral administration in a range of strengths. These typically include tablets of 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg.


Q: Can Distonal interact with herbal remedies like St. John's Wort?

A: Yes. Regulatory warnings indicate that St. John's Wort may interact with this class of medicine. Such an interaction could potentially decrease the effectiveness of the drug or raise the risk of severe side effects like Serotonin Syndrome.


Q: Is Distonal used for anything other than the condition listed in the main description?

A: While its primary regulatory approval is for Major Depressive Disorder (MDD), clinical research has also examined the use of the drug for other conditions. Studies have been conducted on its use for Chronic Neuropathic Pain Syndromes and Bulimia Nervosa, although the evidence quality for these uses varies.


Q: Is it normal to feel slightly dizzy when first starting Distonal?

A: Official documents note that orthostatic hypotension (postural dizziness) is a common side effect of the drug. The regulatory documents also highlight that the risks associated with side effects are typically highest during the initial phase of treatment.


Q: Does Distonal have any known warnings about driving or operating machinery?

A: Regulatory documents advise that this medicine may cause drowsiness or dizziness. Activities requiring mental alertness, such as driving or operating machinery, should be avoided until the individual's response to the drug is known.


Q: Are there any specific foods or drinks that should be avoided while using Distonal?

A: The official instructions state the medicine can be taken with or without food. There are no specific food restrictions cited in the regulatory documents, though official warnings state that alcohol use may need to be addressed due to potential interactions.


Q: Can Distonal affect my vision?

A: Blurred vision has been reported as a common anticholinergic side effect of the medicine. This is a recognized adverse reaction listed in the official product information.


Q: Is it true that research shows Distonal may help with X condition (outside its main use)?

A: Clinical research has examined the drug's use for several conditions beyond its primary indication, such as Chronic Neuropathic Pain Syndromes. The official evidence base indicates that the evidence quality varies across studies for these secondary uses.


Q: How long do clinical studies typically follow patients who are taking Distonal?

A: Official research evidence includes both short-term response monitoring (e.g., 6–8 weeks) and maintenance studies. For the primary indication, these maintenance studies have observed patient outcomes for up to two years.


Q: If I have a kidney or liver condition, can I still take Distonal?

A: Official eligibility information states that use requires extreme caution for patients with significant renal impairment (kidney disease). Since the drug is metabolized in the liver, caution is generally applied to patients with pre-existing hepatic conditions as well.


Q: Is Distonal addictive or habit-forming?

A: While not described as addictive, regulatory documents address discontinuing the medicine by mandating that the dosage must be tapered gradually. This gradual reduction is a standard requirement for medicines that may cause physical discontinuation symptoms if stopped too quickly.


Q: Can Distonal be taken with multivitamins?

A: The official interaction text advises that a healthcare professional should be informed of all products being used, including vitamins and supplements. This allows them to comprehensively assess for any potential interactions that could alter how Distonal works.


Q: Can Distonal cause mood changes or emotional side effects?

A: Yes, the medicine carries a specific regulatory warning about the risk of suicidal ideation and behavior in specific age groups. Other potential mood or behavioral changes reported include anxiety, agitation, panic attacks, and irritability.


Q: What is the general patient expectation for improvement after starting Distonal?

A: The general expectation is that treatment is monitored over several weeks. Clinical trials for the primary use assessed changes in symptoms over short-term intervals (6–8 weeks), which sets the time frame for when initial improvement may be measured.


Q: Why is Distonal described as a 'selective' drug in its mechanism of action?

A: Distonal is classified as a secondary amine Tricyclic Antidepressant (TCA), which provides it with a more selective pharmacological profile. This selectivity is centered on its foundational role as a potent Norepinephrine Reuptake Inhibitor (NRI).


Q: Can people with high blood pressure take Distonal?

A: Regulatory guidance specifies that use requires extreme caution for patients with pre-existing cardiovascular disease. The drug has been associated with potential cardiovascular side effects, including reports of hypertension (high blood pressure) itself.


Q: Does smoking affect how Distonal works in the body?

A: The official regulatory patient information advises individuals to inform their healthcare professional if they smoke. This disclosure is relevant for assessing potential effects on how the drug is processed in the body.


Q: How do I know if I'm ineligible to use Distonal?

A: Official guidance states that the medicine is contraindicated (must not be used) if you have a known allergy to the medicine, are in the acute recovery period following a heart attack, or are currently taking a Monoamine Oxidase Inhibitor (MAOI) drug.


Q: Is Distonal available over the counter in any country?

A: Regulatory documents classify Distonal as a prescription-only medication in the jurisdictions covered by the official information. The classification means that it is not available for purchase without a prescription.


Q: Do studies support the long-term use of Distonal for its primary indication?

A: Clinical research includes maintenance studies that have demonstrated the drug's role in preventing the recurrence of symptoms (relapse) for its primary indication over a period of up to two years. This evidence is part of the long-term data for the medicine.


Q: Is it possible to be allergic to Distonal?

A: Yes. The official label specifies that patients with a known hypersensitivity or allergy to the medicine are contraindicated for its use. This highlights the possibility of an allergic reaction.


Q: What is the typical time frame for seeing the 'full benefit' of Distonal?

A: The full clinical effect can take time to develop. The official time frame for assessing an adequate trial of the treatment is typically over 6 to 8 weeks, which includes the necessary time for gradual dose adjustment.

How should Distonal be stored and disposed of?

How to Store and Dispose of Distonal

Storage Conditions and Handling

Distonal must be stored at Controlled Room Temperature (CRT), maintaining a temperature range between 20 C to 25 C (68 F to 77 F). The medication must be protected from moisture and excessive heat.

To preserve product stability, the container must be kept tightly closed and the medication should remain in its original container until the point of use. Do not use Distonal past the expiration date labeled on the packaging.

Child Safety and Disposal

Storage of Distonal must adhere to child safety standards; the medication must be kept out of the sight and reach of children.

Unused, unneeded, or expired Distonal must be discarded according to local regulatory requirements. It is officially advised not to flush this medication down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Distonal found in:

A-Z Index: